Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Sally Wetten"'
Autor:
Xavier Leleu, Eirini Katodritou, Thomas Kuehr, Evangelos Terpos, Jo Caers, Renato Zambello, Alessandra Brescianini, Tony Liang, Sally Wetten, Sorina N. Badelita
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 174-183 (2023)
Abstract Clinical trials have demonstrated the efficacy and safety of carfilzomib in patients with relapsed/refractory multiple myeloma (RRMM); however, prospective real‐world data are limited. This real‐world, prospective, observational study ev
Externí odkaz:
https://doaj.org/article/37cd25a7f41e48c4ad559bd240ebb922
Autor:
Renato Bassan, Monika Brüggemann, Hoi-Shen Radcliffe, Elizabeth Hartfield, Georg Kreuzbauer, Sally Wetten
Publikováno v:
Haematologica, Vol 104, Iss 10 (2019)
Minimal (or ‘measurable’) residual disease in acute lymphoblastic leukemia appears to be a prognostic indicator, with potential value in informing individualized treatment decisions. Complete understanding of the strength of the association betwe
Externí odkaz:
https://doaj.org/article/e805af1b82014214b36cdbc7b4dc200c
Autor:
Xavier Leleu, Eirini Katodritou, Thomas Kuehr, Evangelos Terpos, Jo Caers, Renato Zambello, Alessandra Brescianini, Tony Liang, Sally Wetten, Sorina N. Badelita
Publikováno v:
eJHaem. 4:174-183
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec9e405ab4e16edb0439b39c4d08158d
https://doi.org/10.1002/jha2.595
https://doi.org/10.1002/jha2.595
Autor:
Evangelos Terpos, Renato Zambello, Xavier Leleu, Thomas Kuehr, Sorina N. Badelita, Eirini Katodritou, Alessandra Brescianini, Tony Liang, Sally Wetten, Jo Caers
Publikováno v:
Cancers; Volume 14; Issue 21; Pages: 5311
This prospective, observational study examined the real-world use of carfilzomib across 11 European countries in adults with relapsed/refractory multiple myeloma (RRMM) who received at least one prior line of therapy. Carfilzomib and dexamethasone (K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af1435f9a896f4a89458460d325fc664
https://doi.org/10.3390/cancers14215311
https://doi.org/10.3390/cancers14215311
Autor:
Hitan Patel, Raghava Nandigam, Drew Provan, Indraraj Umesh Doobaree, Vickie McDonald, Anouchka Seesaghur, Lesley Mensah, Adrian C. Newland, Sally Wetten, Sandrine Leroy
Publikováno v:
European Journal of Haematology
Background Romiplostim is a thrombopoietin-mimetic peptibody for adult refractory chronic immune thrombocytopenia (ITP). We aimed to describe ITP patients receiving romiplostim, platelet counts and romiplostim usage in UK clinical practice. Methods T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26749b7d258770c94b3141b30db17f50
http://europepmc.org/articles/PMC6850028
http://europepmc.org/articles/PMC6850028
Autor:
Alessandra Brescianini, Evangelos Terpos, Renato Zambello, Tony Liang, Jo Caers, Sally Wetten, Thomas Kuehr, Xavier Leleu, Sorina Nicoleta Badelita, Eirini Katodritou
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S160-S161
Background Increasing use of antibodies targeting CD38 in first line (1L) for multiple myeloma (MM) has created a need for treatments for patients who are refractory to anti-CD38. This analysis describes the use of carfilzomib (K) with lenalidomide a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5043699d41434abe4b41567130ae02ef
https://doi.org/10.1016/s2152-2650(21)02347-8
https://doi.org/10.1016/s2152-2650(21)02347-8
Autor:
Louise Taylor, Anouchka Seesaghur, Martin R. Schipperus, Georgia Kaiafa, Georg Kreuzbauer, Sally Wetten, Andy Boshier
Publikováno v:
Drug Safety
Introduction Romiplostim is a subcutaneously administered thrombopoietin-receptor agonist approved in the European Union for self-administration (or administration by a caregiver) in selected adult patients with chronic primary immune thrombocytopeni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c613ea46a4c680442216f3f1de0293d
https://doi.org/10.1007/s40264-018-0723-6
https://doi.org/10.1007/s40264-018-0723-6
Autor:
Eirini Katodritou, Thomas Kühr, Abeera Mohammad, Evangelos Terpos, Borhane Slama, Sally Wetten, Sorina Nicoleta Badelita, Xavier Leleu, Renato Zambello, Jo Caers, Florence Suzan
Publikováno v:
Blood. 136:38-39
Background: To understand carfilzomib (K) usage, effectiveness and safety in patients (pts) with relapsed or refractory multiple myeloma (RRMM) in real-life, we describe the results of an interim analysis by K-based regimens from a large prospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0b8e099b217b5841fc69fdeb64956b4
https://doi.org/10.1182/blood-2020-134475
https://doi.org/10.1182/blood-2020-134475
Autor:
Thomas Kühr, Xavier Leleu, Jo Caers, Abeera Mohammad, Evangelos Terpos, Florence Suzan, Borhane Slama, Sorina Nicoleta Badelita, Eirini Katodritou, Renato Zambello, Sally Wetten
Publikováno v:
Blood. 136:9-10
Background: With approvals of lenalidomide (Len) based therapy for the treatment of transplant ineligible patients (pts) with newly diagnosed multiple myeloma, and for pts receiving maintenance following transplant, there is an increasing use of Len
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8255f0a110995dd1f242afe959f6b60
https://doi.org/10.1182/blood-2020-134476
https://doi.org/10.1182/blood-2020-134476
Autor:
Sebastian Giebel, Fabio Ciceri, Bipin N. Savani, Ariane Boumendil, Arnon Nagler, Christoph Schmid, Mohamad Mohty, Myriam Labopin, Frédéric Baron, Anouchka Seesaghur, Sally Wetten, Norbert Claude Gorin, Jordi Esteve
Publikováno v:
Annals of Hematology
Hematopoietic stem cell transplantation (HSCT) is considered an effective way to prevent relapse in adults with acute lymphoblastic leukemia (ALL). This study aimed to assess general trends in the use of various types of HSCTs performed between 2001
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::209bd3890bad52b0c9fd98483e03d4d5
https://pubmed.ncbi.nlm.nih.gov/31392462
https://pubmed.ncbi.nlm.nih.gov/31392462